https://nl.marketscreener.com/koers/aandeel/ATOSSA-THERAPEUTICS-INC-42859369/nieuws/Atossa-Therapeutics-Inc-Presenteert-gegevens-van-het-40mg-cohort-van-de-Fase-2-EVANGELINE-klinisch-46398769/?utm_source=telegram&utm_medium=social&utm_campaign=share